Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's Disease

NCT01282619 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

390

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: Huperzine A
DRUG: huperzine A
DRUG: Placebo

Sponsor

Shandong Luye Pharmaceutical Co., Ltd.